Clinical Research Directory
Browse clinical research sites, groups, and studies.
Effect of add-on Doxofylline on Lung Function in Stable COPD
Sponsor: University of Milan
Summary
It is a phase IV, prospective, interventional, single blind, randomized, crossover trial in which the investigators will evaluate the effects of a 4-week treatment with doxofylline 400 mg bid, in add-on to maximal inhalation therapy, in clinically stable COPD patients.
Official title: Effect of Doxofylline on Bronchial Obstruction, in add-on to Maximal Inhalation Therapy, in Clinically Stable COPD Patients.
Key Details
Gender
All
Age Range
40 Years - Any
Study Type
INTERVENTIONAL
Enrollment
78
Start Date
2026-12-01
Completion Date
2027-12-30
Last Updated
2026-04-29
Healthy Volunteers
No
Conditions
Interventions
Doxofylline
Patients will receive a 4-week treatment with doxofylline 400 mg bid, in addition to their chronic usual inhalation therapy.
Locations (1)
L. Sacco Hospital
Milan, Italy